Find clinical trials for COVID-19 in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Communicable Diseases
Coronavirus Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Respiratory Distress Syndrome

COVID-19 trials near Montréal, QC, CAN:

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19

COVID-19 patients who develop severe disease often develop acute respiratory distress syndrome (ARDS) as a result of a dysregulated...

Other: SOC plus Placebo IV
Biological: SOC plus 15mg/kg EB05 IV

Phase 2, Phase 3

Edesa Biotech

Montréal, Quebec, Canada and 19 other locations

This study is an adaptive, randomized, open-label, controlled clinical trial, in collaboration with countries around the world through the World Heal...

Active, not recruiting
Drug: LSALT Peptide
Drug: Imatinib

Phase 3

Sunnybrook Health Sciences Centre

Montréal, Quebec, Canada and 52 other locations

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting
COVID-19 Disease
Drug: Placebo oral capsule
Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Montréal, Quebec, Canada and 28 other locations

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3


Pointe-Claire, Quebec, Canada and 217 other locations

The purpose of this study is to find out if immunization with IMM-101 will reduce the incidence of severe respiratory and COVID-19 ...

Active, not recruiting
Other: Observation
Biological: IMM-101

Phase 3

Canadian Cancer Trials Group

Montreal, Quebec, Canada and 7 other locations

proteins of three coronaviruses: SARS-CoV-2 (the virus that causes COVID-19 disease), SARS-CoV-1 and MERS-CoV. The trivalent vaccin...

Active, not recruiting
Coronavirus Infections
Biological: VBI-2901a

Phase 1

VBI Vaccines

Pointe-Claire, Quebec, Canada and 6 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3


Montreal, Quebec, Canada and 214 other locations

The main goals of this study are to assess the immune response and safety of two different vaccines for first, second, third and fourth doses as well...

Active, not recruiting
Biological: Covifenz
Other: 0, 28 day schedule

Phase 2

Canadian Immunization Research Network

Montréal, Quebec, Canada and 7 other locations

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Drug: Intramuscular injection
Biological: Intramuscular vaccine

Phase 2, Phase 3


Pierrefonds, Quebec, Canada and 90 other locations

ESSOR is a double-blind, placebo-controlled study of the orally-administered antiviral and inflammation-controlling LAU-7b for the treatment of adult...

Active, not recruiting
Drug: LAU-7b for 3 cycles
Drug: LAU-7b for 1 cycle, then placebo

Phase 2, Phase 3

Laurent Pharmaceuticals

Montréal, Quebec, Canada and 4 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems